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The a5 chain-containing laminin isoforms, laminins-10
and -11 (laminin-10/11), are the major components of the
basement membrane, having potent cell-adhesive activ-
ity. We examined the cell-adhesive and integrin-medi-
ated signaling activities of laminin-10/11 in comparison
to fibronectin, the best characterized extracellular ad-
hesive ligand. We found that laminin-10/11 are more ac-
tive than fibronectin in promoting cell migration and
preferentially activate Rac, not Rho, via the p130Cas-
CrkII-DOCK180 pathway. Cells adhering to fibronectin
develop stress fibers and focal contacts, whereas cells
adhering to laminin-10/11 do not, consistent with the
high cell migration-promoting activity of laminin-10/11.
Pull-down assays of GTP-loaded Rac and Rho demon-
strated the preferential activation of Rac on laminin-10/
11, in contrast to the activation of Rho on fibronectin.
Activation of Rac by laminin-10/11 was associated with
the phosphorylation of p130Cas and an increased forma-
tion of a p130Cas-CrkII-DOCK180 complex. Cell migra-
tion on laminin-10/11 was suppressed by the expression
of either a dominant-negative Rac or CrkII mutants de-
fective in p130Cas or DOCK180 binding. This is the first
report demonstrating a distinct activation of Rho family
GTPases resulting from adhesion to different extracel-
lular ligands.
Many cellular processes, such as growth, survival, and mi-
gration, require both soluble growth factors and integrin-me-
diated adhesion to the extracellular matrix (ECM).1 Growth
factor-induced signaling occurs within integrin-containing ad-
hesion complexes (1, 2), assembly of which is regulated by the
Rho family of GTPases. Activation of Rho induces the bundling
of actin filaments into stress fibers and the clustering of inte-
grins into focal contacts; activation of Cdc42 or Rac results in
the formation of long, thin actin-containing extensions called
filopodia and curtain-like extensions called lamellipodia, re-
spectively (3).
The ligation of integrins triggers a multitude of signaling
events, including activation of tyrosine kinases and subsequent
phosphorylation of multiple cellular proteins such as focal ad-
hesion kinase (FAK), p130Cas, and paxillin. This cascade leads
to the formation of signaling complexes by the coupling of
signaling molecules with adaptor proteins containing SH2
and/or phosphotyrosine binding domains (1, 2). FAK plays a
central role in integrin-mediated signal transduction through
its association with Src family kinases, p130Cas, Shc, Grb2, and
phosphatidylinositol 3-kinase, leading to activation of the mi-
togen-activated protein kinase pathways (4). p130Cas couples to
FAK through an SH3 domain and to CrkII through a tyrosine-
phosphorylated substrate domain. The p130Cas-CrkII complex
has been shown to serve as a molecular switch regulating
integrin-mediated cell spreading and migration over an ECM-
coated substratum through coupling with DOCK180, a guanine
nucleotide exchange factor for Rac (5–7). Src family kinases are
the major protein tyrosine kinases that phosphorylate FAK,
p130Cas, and other signaling proteins; tyrosine phosphorylation
of these proteins is eliminated in cells with the triple mutation
of the Src, Yes, and Fyn kinases (8).
There are more than 20 different integrin types, each having
distinct ligand binding specificities. Gene knockout studies
demonstrate that different integrin types have unique, irre-
placeable functions, vascular defects in a5 integrin-null mice
and epithelial defects in a3 or a6 integrin-null mice (9). Never-
theless, most studies of integrin-mediated signaling events
have been performed on cells adhering to fibronectin (FN)
through a5b1 integrin. The signaling events transduced by
other integrin types remain unclear, particularly those con-
taining a3- or a6-subunits that bind to laminins. In addition, it
is also not known how these signals differ from those trans-
duced by a5b1 integrin.
Laminins are the major components of the basement mem-
brane. Cells bind directly to laminins via a subset of integrins
and other non-integrin-type receptors, such as dystroglycans.
All laminins are composed of an a, b, and g chain. At least 12
members of the laminin family have been identified, each com-
posed of a distinct combination of heterotrimers (10–12). Of
particular interest are those containing a5 chain, as embryos
lacking the laminin a5 chain die late in embryogenesis without
anterior neural tube closure or digit septation (13). The laminin
a5 gene is expressed in fetal and adult tissues, including the
kidney, lung, skeletal muscle, skin, and intestine (14, 15).
These results suggest the a5-containing laminins, laminin-10
(a5b1g1) and laminin-11 (a5b2g1), have important roles in de-
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velopment and establishment of tissue architecture. Recently,
we purified laminin-10/11 (LN-10/11) from the conditioned me-
dium of A549 human lung carcinoma cells to find that the a3b1
integrin is the preferred receptor for LN-10/11, although a6b1
integrin serves as another LN-10/11 receptor in fibroblastic
cells (16, 17). The mechanisms governing cell behavior on LN-
10/11 and the signals transduced by a3b1 and other cognate
integrins, however, remain unclear.
In the present study, we examined the integrin-mediated
signaling events resulting from adhesion to LN-10/11, com-
pared against those from FN. LN-10/11 preferentially activate
Rac, but not Rho, through an a3b1 integrin-dependent pathway
involving a p130Cas-CrkII-DOCK180 complex, thereby strongly
promoting cell migration through enhanced lamellipodia for-
mation. FN, however, preferentially activates Rho, leading to
enhanced stress fiber and focal contact formation.
EXPERIMENTAL PROCEDURES
Cells and Cell Culture—A549 human lung adenocarcinoma cells and
ECV304 human endothelia-derived cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (FBS) at 37 °C in a humidified atmosphere containing 5% CO2.
The MKN45 human gastric carcinoma cells were grown in RPMI 1640
containing 10% FBS.
Reagents and Antibodies—Monoclonal antibodies (mAbs) against
Rac, CrkII, phosphotyrosine (PY20), paxillin, FAK, and the horseradish
peroxidase-conjugated, anti-phosphotyrosine (RC20) antibodies were
obtained from Transduction Laboratories (San Diego, CA). Polyclonal
antibodies against p130Cas, DOCK180, and Rho were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). The mAb against the
human a6 integrin subunit (GoH3) was obtained from Cosmo Bio (To-
kyo, Japan). mAbs against integrin av and b4 (ASC-8) were purchased
from Telios Pharmaceuticals (San Diego, CA) and Chemicon (Temecula,
CA), respectively. The mAbs against a3 (3G8), a5 (5G10), and b1 (4G2)
integrins were produced and characterized in our laboratory (16, 18).
F-actin was detected by rhodamine-labeled phalloidin obtained from
Molecular Probes (Eugene, OR). The FITC-conjugated rabbit secondary
antibody to mouse IgG was purchased from Cappel (West Chester, PA).
Preparation of LN-10/11 and LN-5—LN-10/11 were purified to ho-
mogeneity from conditioned media of A549 cells as described previously
(16). The 5D6 mAb, recognizing human laminin a5 chain, was used for
immunoaffinity chromatography (19). Silver staining and immunoblot-
ting with a panel of mAbs specific for individual laminin a chains
verified that the purified LN-10/11 lacked other laminin isoforms (19).
LN-5 was purified from the conditioned media of MKN45 cells by
immunoaffinity chromatography using an anti-laminin g2 chain anti-
body (20).
Expression Plasmids—The pcDNA-CrkII expression plasmid, gener-
ated by transferring the CrkII cDNA insert from pCEFL-GST-CrkII to
pcDNA-3.1 after BamHI and NotI digestion, was the gift of Drs. Taka-
hisa Takino and Kenneth Yamada (NIDCR, National Institutes of
Health). The CrkII N-terminal SH3 mutant (CrkII-SH3M) and SH2
mutant (CrkII-SH2M) were generated by the substitution of leucine for
tryptophan 169 and arginine 38, respectively, using the QuikChangey
site-directed mutagenesis kit (Stratagene, La Jolla, CA). The expres-
sion plasmid for the dominant-negative RacAsn-17 was kindly provided
by Dr. Kenneth Yamada (NIDCR, National Institutes of Health). The
puromycin resistance plasmid pHA262pur was provided by Dr. Hein te
Riele (The Netherlands Cancer Institute, Amsterdam). The expression
plasmids for GST-RB (a fusion protein of glutathione S-transferase to
the Rho-binding domain of bovine Rho kinase) and GST-CRIB (a fusion
protein of glutathione S-transferase to the Cdc42/Rac interactive-bind-
ing domain of PAK1) were kindly provided by Dr. Kozo Kaibuchi (Nara
Institute of Science and Technology, Japan).
Transfection and Selection—Thirty mg of each expression plasmid
were co-transfected with 5 mg of pHA262Puro into 3 3 106 A549 cells by
electroporation at 170 V and 960 microfarads with a Bio-Rad Gene
Pulser. To increase expression of transfected genes, 5 mM sodium bu-
tyrate was included in the culture media. Cells were subcultured at a
1:3 dilution 12 h after transfection and maintained for 48 h in 1 mg/ml
puromycin-containing medium. Before use, cells were cultured over-
night in the absence of puromycin.
Flow Cytometry—Flow cytometric analysis was performed as de-
scribed previously (20). Suspended A549 cells were incubated with
anti-integrin mAbs (anti-a3, a5, a6, av, b1, and b4) for 30 min at 4 °C.
Following washing, cells were incubated with FITC-labeled secondary
antibody for 30 min at 4 °C. Cells were then analyzed on a FACScan
flow cytometer (Becton Dickinson, San Jose, CA).
Immunoprecipitation and Western Blotting—Twenty four hours after
serum starvation, A549 cells with or without transfected plasmids were
detached from culture flasks by treatment with 0.05% trypsin/EDTA,
washed with serum-free DMEM containing 1% bovine serum albumin
(BSA), and resuspended in the same medium. Cells were kept in sus-
pension for 60 min at 37 °C on a rotator. 2 3 106 cells were allowed to
spread on 60-mm tissue culture dishes coated with 5 nM of LN-10/11 or
20 nM of FN for 30 min. Following washing in ice-cold phosphate-
buffered saline (PBS), cells were solubilized in 600 ml of 1% Triton lysis
buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM
sodium vanadate, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 1 mM phen-
FIG. 1. Flow cytometric analyses of integrin subunits on A549
cells. A549 cells were incubated with mAbs specific to a3, a5, a6, av, b1,
or b4 integrin subunits and then stained with FITC-conjugated second-
ary antibody for flow cytometric analysis. The expression of each inte-
grin subunit is shown as a gray line. The black area indicates the
negative control following incubation with mouse IgG.






















ylmethylsulfonyl fluoride). The cell lysates were clarified by centrifu-
gation at 20,000 3 g for 15 min at 4 °C. Proteins were then immuno-
precipitated from the lysates using a combination of 3 mg of specific
mAbs and protein A-Sepharose beads. Immunoprecipitates were sus-
pended in reducing or nonreducing sample buffer, heated to 100 °C for
3 min, resolved on 8 or 10% SDS-polyacrylamide gels, and electro-
phoretically transferred to nitrocellulose membranes. Immunoblots for
phosphotyrosine, FAK, p130Cas, CrkII, DOCK180, or other epitopes
were visualized by ECL (Amersham Pharmacia Biotech).
Detection of GTP-loaded Rho and Rac—A549 cells were serum-
starved overnight, detached in trypsin/EDTA, and kept in suspension in
DMEM with 1% BSA for 90 min. Cells were plated on dishes coated
with indicated concentrations of LN or FN. At the times indicated, cells
were washed with ice-cold PBS and then lysed in buffer containing 1%
Nonidet P-40, 50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 10 mM MgCl2, 1
mM dithiothreitol, 10 mg/ml leupeptin, 10 mg/ml aprotinin, and 1 mM
phenylmethylsulfonyl fluoride. Lysates were clarified by centrifugation
at 20,000 3 g for 15 min at 4 °C and then incubated with either 30 mg
of GST-CRIB or GST-RB for 60 min at 4 °C with 30 ml of glutathione-
agarose beads. The immunoprecipitates were washed three times with
lysis buffer, and then resolved on 12% SDS-polyacrylamide gels. Fol-
lowing electrophoretic transfer to nitrocellulose, the membranes were
immunoblotted using anti-Rac mAb or polyclonal anti-Rho antibody.
Whole cell lysates were also directly immunoblotted for the levels of
total Rac or Rho for normalization.
Cell Motility Assays—A549 cells were replated on 50-mm glass mi-
crowell dishes (Matsunami, Co., Osaka, Japan) coated with either LN-
10/11 (5 nM) or FN (20 nM) in serum-free DMEM and blocked with 1%
BSA. Thirty minutes post-replating, the medium was changed to that
containing 1% FBS with or without 10 mg/ml antibodies as indicated.
Cell migration was then monitored using a Zeiss S-25 inverted micro-
scope. Video images were collected with a CCD camera at 20-min
intervals using the Image-Pro software (Media Cybernetics, Silver
Springs, MD). The positions of nuclei were tracked to quantify cell
motility. Velocities were calculated in micrometers per 8 h using the
same software.
Immunofluorescence Microscopy—Glass coverslips were coated with
LN (10 nM) or FN (40 nM) in PBS overnight at 4 °C and then blocked
with 1% BSA. A549 cells were serum-starved overnight and then re-
plated on the coverslips by incubating for 1 h in DMEM containing 1%
BSA. Cells were then fixed with 3.7% paraformaldehyde in PBS for 20
min and permeabilized with 0.5% Triton X-100 for 5 min. Focal adhe-
sions were visulized by incubating cells with mouse anti-paxillin anti-
body, following an incubation with FITC-conjugated rabbit antibody
specific for mouse IgG. Actin filaments were stained with rhodamine-
conjugated phalloidin.
RESULTS
LN-10/11 Stimulate Cell Migration via a3b1 Integrin—Our
previous studies demonstrate that LN-10/11 are very potent
cell-adhesive proteins capable of utilizing both a3b1 and a6b1
integrins as major surface receptors (17). The adhesion of A549
cells onto LN-10/11, however, depends predominantly on a3b1
integrin (16). This apparent discrepancy is due to the marginal
expression level of a6b1 integrin in A549 cells, as opposed to a
high expression level of a3b1 integrin (Fig. 1). Integrin a5b1, the
major receptor for FN, was expressed at lower levels than a3b1
on A549 cells. Consistent with the relative expression of a3b1
and a5b1 integrins, the maximal level of A549 cell adhesion was
attained at lower coating concentrations of LN-10/11 than FN
(16). In our cell adhesion assays, the degree of A549 cell adhe-
sion to substrates was comparable and close to the maximal
level when coated with either 5 nM LN-10/11 or 20 nM FN.
Unless otherwise specified, therefore, we have compared cellu-
lar responses to LN-10/11 and FN at these coating
concentrations.
We compared the activity of LN-10/11 and FN to promote cell
migration using time-lapse video microscopy (Fig. 2). The mi-
gration of A549 cells was significantly faster on LN-1oin the
migration of A549 cells on LN-10/11, we examined the effects of
function-blocking antibodies against a3, a6, and b1 integrin
chains on A549 cell migration. Anti-a3 and anti-b1 antibodies,
but not anti-a6 antibody, inhibited cell migration on LN-10/11
FIG. 2. Migration of A549 cells on LN-10/11 is mediated by a3b1 integrin. A549 cells were replated on dishes coated with FN (10 or 25 nM)
or LN-10/11 (5 nM) in the presence of 1% FBS and anti-integrin antibodies (10 mg/ml). Cell movements were monitored by time-lapse video
microscopy. Cell motility was evaluated by velocity (mm/8 h), determined using Image-Pro software as described under “Experimental Procedures.”
Antibodies used were anti-a3, -a6, or -b1 mAbs as well as control mouse IgG. A, representative paths of cell movements on LN-10/11 (5 nM) or FN
(10 nM) tracked at 20-min intervals over a span of 8 h. B, quantification of cell motility as expressed as the mean 6 S.D. in triplicate assays.
Statistical analysis was performed using Student’s t test. *, p , 0.01; **, p , 0.001; ***, p . 0.05.






















(Fig. 2). These results were consistent with previous observa-
tions that the attachment of A549 cells on LN-10/11 was inhib-
ited by anti-a3, but not anti-a6, antibodies (16). The adhesive
interaction of A549 cells with LN-10/11, therefore, is largely
dependent on a3b1 integrin.
LN-10/11 Do Not Induce the Formation of Stress Fibers and
Focal Contacts—To explore differences in signals transduced
from LN-10/11 and FN, we examined the reorganization of the
actin cytoskeleton and the formation of focal contacts in A549
cells adhering to either LN-10/11 or FN. Actin reorganized into
microfilament bundles in cells spread on FN, although the cells
plated on LN-10/11 contained short, thin actin filaments form-
ing lamellipodia at the cell periphery (Fig. 3A). Clear focal
contacts, visualized using an anti-paxillin antibody, were de-
tected in cells spread on FN but not on LN-10/11. We extended
this observation to other cell types by examining the actin
cytoskeleton and focal contact formation in ECV304 cells (Fig.
3B). These cells, when adhered to FN, demonstrated well or-
ganized actin stress fibers and clear focal contacts; cells spread
on LN-10/11 contained thin, short actin filaments arranged
circumferentially without clear focal contacts.
LN-10/11 and FN Differentially Regulate Rac and Rho Ac-
tivation—Cytoskeletal reorganization associated with cell
spreading is regulated by the Rho family of small GTPases. Rho
activation controls the assembly of stress fibers and focal ad-
hesions; activation of Cdc42 and Rac results in the formation of
filopodia and lamellipodia, respectively (21). To examine the
differential activation of Rac and Rho by LN-10/11 and FN, the
quantities of GTP-loaded Rac and Rho were determined by
pull-down assays, based on their specific binding to the GST-
CRIB (a fusion protein containing the Cdc42/Rac-binding do-
main of PAK1) and GST-RB (a fusion protein containing Rho-
binding domain of Rho kinase). Serum-starved A549 cells were
detached and kept in suspension for 90 min and then replated
on either LN-10/11 or FN-coated dishes. The level of GTP-
bound Rho was significantly elevated on FN as early as 10 min
(Fig. 4A). Only a marginal increase in the level of GTP-Rho was
observed in cells adhering to LN-10/11. In contrast, a signifi-
cant increase in Rac activation was observed in cells adhering
to LN-10/11, not FN. The complementary profiles of Rho and
Rac activation on FN and LN-10/11 were preserved even at
higher ligand coating concentrations (Fig. 4B), indicating that
signals transduced from FN and LN-10/11 are distinct in their
activation of Rho family GTPases.
LN-10/11 Preferentially Phosphorylate p130Cas—The activa-
tion of integrins upon cell adhesion to the ECM leads to an
increase in the phosphorylation of FAK and p130Cas (22). To
explore the differences in the signaling pathways mediated by
LN-10/11 and FN, we examined the phosphorylation of FAK
and p130Cas in A549 cells plated on either FN, LN-10/11, or
LN-5. LN-5 was included as a control ligand binding to a3b1
integrin (20, 23). Although the phosphorylation of FAK and
p130Cas increased in cells adhering to these proteins, FAK
phosphorylation levels were much higher on FN than on LN-
10/11 or LN-5 (Fig. 5A). Conversely, the level of p130Cas phos-
phorylation was higher on LN-10/11 and LN-5 than on FN (Fig.
5B). Densitometric analysis demonstrated that the ratio of
phosphorylated FAK to phosphorylated p130Cas in the cells
spread on FN was two times greater than in cells plated on
either LN-10/11 or LN-5 (Fig. 5C), suggesting that LN-10/11
and FN activate distinct integrin-mediated signaling
pathways.
LN-10/11 Enhance Formation of the p130Cas-CrkII-
DOCK180 Complex—The association of p130Cas with the adap-
tor protein CrkII is important in cell migration over the ECM
(5). Tyrosine phosphorylation promotes the coupling of p130Cas
to CrkII, in turn coupling to downstream effectors such as
DOCK180 (6). To determine whether the increased p130Cas
phosphorylation on LN-10/11 is associated with increased for-
mation of the p130Cas-CrkII-DOCK180 complex and subse-
quent Rac activation, we transfected either the wild-type CrkII
or its N-terminal SH3 mutant form (CrkII-SH3M) together
with the puromycin selection plasmid into A549 cells. The
FIG. 3. Cytoskeletal reorganization and focal contact forma-
tion in the presence of LN-10/11 or FN. Serum-starved A549 cells
(A) or ECV304 cells (B) were allowed to spread on coverslips coated with
FN (20 nM; upper panels) or LN-10/11 (10 nM; lower panels) for 1 h in
DMEM containing 1% BSA. Cells were then stained with rhodamine-
phalloidin to detect F-actin (left) or anti-paxillin antibody to detect focal
adhesions (right). The thick and thin arrows specify stress fibers and
short actin filaments, respectively. The large and small arrowheads
designate focal contacts and membrane ruffles, respectively.
FIG. 4. Differential activation of Rho and Rac on LN-10/11 and
FN. A, serum-starved A549 cells were detached and held in suspension
for 90 min and then replated on dishes coated with LN-10/11 (5 nM) or
FN (20 nM) for 10 or 30 min. Cell lysates were incubated with GST-RB
or GST-CRIB immobilized on agarose beads. GTP-loaded Rho and Rac
were detected by Western blotting (upper panels). Total cell lysates
were also probed for Rho or Rac to demonstrate equal amounts of total
protein (lower panel). B, serum-starved cells were replated on dishes
coated with different concentrations of LN-10/11 or FN for 30 min. The
levels of GTP-loaded and total Rho and Rac were detected as described
above. Sus, cells kept in suspension. The results shown are represent-
ative of three independent experiments.






















mutant CrkII is defective in the coupling to downstream effec-
tors. After selection with puromycin for 2 days, the surviving
cells were starved in medium containing 0.2% serum for 24 h.
CrkII was immunoprecipitated from cell lysates with anti-
CrkII, followed by immunoblotting with either anti-p130Cas or
anti-DOCK180. In wild-type CrkII transfectants, both p130Cas
and DOCK180 were associated with CrkII in cells adhering to
LN-10/11 (Fig. 6). Only marginal amounts of p130Cas and
DOCK180 were associated with CrkII in cells adhering to FN,
suggesting that LN-10/11 preferentially enhance the formation
of the p130Cas-CrkII-DOCK180 complex. Consistent with these
results, DOCK180 was not immunoprecipitated in association
with CrkII from cells expressing the CrkII SH3 mutant, even
though the association of p130Cas with CrkII was unaffected.
These results confirm that the N-terminal SH3 domain of CrkII
is essential for DOCK180 binding (6).
Overexpression of CrkII SH3 Mutant Inhibits Rac Activation
on LN-10/11—DOCK180 activates Rac through binding to the
CrkII-p130Cas complex (6). The CrkII SH3 mutant cannot as-
sociate with DOCK180; therefore, we examined the inhibition
of Rac activation by the CrkII SH3 mutant upon plating trans-
fected cells on LN-10/11. The levels of GTP-bound Rac in the
presence of LN-10/11 were elevated in cells transfected with
wild-type CrkII; this activation was blocked in cells transfected
with the CrkII SH3 mutant (Fig. 7, A and C). In contrast, Rho
activation after plating cells on FN was not affected by expres-
sion of the CrkII SH3 mutant (Fig. 7, B and D). These results
suggest that, in A549 cells, LN-10/11 activate Rac through the
p130Cas-CrkII-DOCK180 pathway.
Overexpression of CrkII SH3 or SH2 Mutants Inhibits Cell
Migration on LN-10/11—To confirm the involvement of CrkII
in cell migration on LN-10/11-coated substrates, A549 cells
were transfected with either a dominant-negative Rac
(RacAsn-17) or CrkII SH2 and SH3 mutants, each defective in
coupling to p130Cas or DOCK180, respectively. We measured
the migration of these transfectants over LN-10/11-coated sub-
strates using time-lapse video microscopy. Under the condition
where the levels of expression of wild-type and mutant CrkII
were comparable and 4–6-fold greater than that of endogenous
CrkII (Fig. 8B), transfection of either the CrkII SH2 or SH3
mutant reduced cell migration to 50 and 53% of control cells
transfected with a puromycin resistance plasmid alone, respec-
tively, although transfection of wild-type CrkII had little effect
on cell migration (Fig. 8A). Incomplete inhibition of cell migra-
tion by transfection of CrkII SH2 or SH3 mutants may result
from the presence of other signaling pathways regulating inte-
grin- and growth factor-mediated cell migration like the mito-
gen-activated protein kinase pathways (24, 25). Overexpres-
sion of a dominant-negative Rac also reduced cell migration on
LN-10/11 to 45% of control cells, confirming that Rac activation
plays a crucial role in cell migration over LN-10/11.
DISCUSSION
In this study, we explored the mechanisms of cell spreading
and migration over LN-10/11 with an emphasis on integrin-
mediated signaling pathways. By using transfection of wild-
type or dominant-negative signaling molecules together with
biochemical analyses, we found that LN-10/11 and FN have
distinct effects on cell spreading and migration as summarized
in Fig. 9. LN-10/11 induce the formation of protrusive struc-
tures such as membrane ruffles and lamellipodia; FN enhances
the formation of actin stress fibers and focal contacts. Consist-
ent with these morphological distinctions, LN-10/11 are more
potent than FN in promoting cell migration. LN-10/11 prefer-
entially activate Rac, not Rho, whereas Rho, not Rac, is acti-
vated by FN. Rac activation is required for cell migration on
LN-10/11, since cell migration is down-regulated in cells over-
expressing a dominant-negative RacAsn-17. Rac activation on
LN-10/11 is mediated by the p130Cas-CrkII-DOCK180 pathway
since (a) p130Cas is preferentially tyrosine-phosphorylated in
cells adhering to LN-10/11 as compared with cells adhering to
FN; (b) the association of CrkII with p130Cas and DOCK180 is
enhanced in cells adhering to LN-10/11, not FN; and (c) LN-
10/11-mediated Rac activation is abolished by overexpression
of a CrkII SH3 mutant. Both CrkII SH2 and SH3 mutants, as
well as RacAsn-17, inhibit cell migration on LN-10/11, indicating
FIG. 5. Differential phosphorylation of FAK and p130Cas on
LN-10/11 and FN. Serum-starved A549 cells were detached and held in
suspension for 60 min and then replated on the dishes coated with
LN-10/11 (5 nM) or FN (20 nM) for 30 min. Cell lysates were immuno-
precipitated with antibodies against FAK (A) or p130Cas (B). Immuno-
precipitates were then immunoblotted with either anti-phosphotyrosine
antibody to detect phosphorylated FAK (P-FAK) and p130Cas (P-
p130Cas) or anti-FAK and anti-p130Cas antibodies to detect total FAK
(T-FAK) and total p130Cas (T-p130Cas), respectively. Sus, cells kept in
suspension. C, the ratios of phosphorylated FAK to phosphorylated
p130Cas were determined by densitometry of the bands on immunoblots
after normalization against the band intensities of total FAK and
p130Cas. The data are expressed as relative values after normalization
against the ratio in the cells in suspension. The results shown are
representative of two independent experiments.
FIG. 6. Effects of LN-10/11 and FN on p130Cas-CrkII-DOCK180
complex formation. A549 cells were co-transfected with pHA262pur
and plasmids encoding either wild-type CrkII (Wt) or CrkII N-terminal
SH3 mutant (SH3M). After selection with puromycin for 2 days, cells
were serum-starved overnight in 0.2% FBS, detached, and held in
suspension for 60 min. Cells were either kept in suspension (Sus) or
replated on the dishes coated with LN-10/11 (5 nM) or FN (20 nM) for 30
min. CrkII was immunoprecipitated (IP) from cell lysates utilizing an
anti-CrkII antibody, and the precipitates were detected by immunoblot-
ting with an anti-p130Cas (top), anti-DOCK180 (middle), or anti-CrkII
(bottom) antibody. The data shown are representative of two independ-
ent experiments.






















that LN-10/11 promote cell migration by preferential activation
of Rac through the p130Cas-CrkII-DOCK180 pathway.
Different Signals are Transduced by a3b1 and a5b1 Inte-
grins—Ligand binding to integrins activates intracellular sig-
naling cascades, which regulate various cellular functions in-
cluding cytoskeletal organization and cell proliferation and
differentiation. Up to 25 integrin ab heterodimers have been
identified; the a5b1 integrin has been most extensively studied
as a model for integrin signaling through its specific interaction
with FN, a well characterized ECM ligand containing an RGD
motif. Many integrin-mediated signaling events, including ty-
rosine phosphorylation of FAK, p130Cas, paxillin, and other
adapter proteins, activation of the Rho family of small
GTPases, and activation of mitogen-activated protein kinases
and subsequent cell cycle progression, have been elucidated in
cells adhering to FN through a5b1 integrin (2, 22, 26). Despite
extensive studies of signaling events involving a5b1 and other
integrins recognizing an RGD motif, little is known about sig-
naling through RGD-independent integrins, particularly those
recognizing LNs. Signals transduced from LN-1 and FN
through a6b1 and a5b1 integrins, respectively, are likely to
antagonistically regulate cell proliferation and differentiation.
FIG. 7. Overexpression of the CrkII SH3 mutant inhibits Rac activation on LN-10/11-coated substrates. A549 cells, transfected with
either wild-type CrkII (Wt) or CrkII SH3 mutant (SH3M) were selected with puromycin as described in Fig. 6. Serum-starved transfectants were
detached, held in suspension for 60 min, and then either kept in suspension (Sus) or replated on dishes coated with LN-10/11 (5 nM) or FN (20 nM)
for 30 min. Cell lysates were incubated with either GST-CRIB or GST-RB immobilized on glutathione-agarose beads. Bound GTP-loaded Rac and
Rho were detected by immunoblotting with anti-Rac (A) or Rho (B) antibodies (upper panels). Cell lysates were also directly probed for total Rac
or Rho (lower panels). The intensities of the bands of GTP-loaded Rac (C) and Rho (D) relative to those of total Rac/Rho were quantified by
densitometry. The data shown represent the mean 6 S.E. of two independent experiments, expressed as relative values after normalization against
the ratio in the cells kept in suspension.
FIG. 8. Overexpression of CrkII SH2 and SH3 mutants inhibits
cell motility. A549 cells were co-transfected with pHA262pur and
plasmids encoding either the wild-type CrkII (Wt), CrkII SH2 mutant
(SH2M), CrkII N-terminal SH3 mutant (SH3M), or dominant-negative
Rac (N17Rac). Transfectants, selected with puromycin (Puro), were
replated on dishes coated with LN-10/11. Cell movements were moni-
tored by time-lapse video microscopy. A, cell motility, determined using
Image-Pro software, was expressed as velocity (mm/8 h). Data shown
are the mean 6 S.D. from three independent experiments. Statistical
analysis was performed using Student’s t test. *, p , 0.01 versus control.
N17Rac, RacAsn-17. B, the expression levels of wild-type or mutant CrkII
were detected by immunoblotting with anti-CrkII antibody. Ctr, cells
transfected with pHA262pur alone.
FIG. 9. Proposed schemes of the integrin-mediated signaling
pathways differentially activated by LN-10/11 and FN. Engage-
ment of a3b1 and a5b1 integrins with LN-10/11 or FN induces differen-
tial tyrosine phosphorylation of FAK and p130Cas, activating distinct
downstream signaling pathways, featuring distinctive activation of Rho
and Rac. Our results indicate that a3b1 integrin-mediated signals pref-
erentially activate Rac through the p130Cas-CrkII-DOCK180 pathway,
whereas a5b1 integrin-mediated signals lead to Rho activation via an
undefined pathway. Recently, Rac activation has been shown to down-
regulate Rho activity (dashed line; see Refs. 43–45).






















FN suppresses differentiation to promote the proliferation of
myoblasts, whereas LN-1 has the opposite effect (27). Consist-
ent with this observation, transfection of the cytoplasmic do-
main of a6 integrin subunit promotes myoblast differentiation,
whereas transfection of the cytoplasmic domain of a5-subunit
suppresses differentiation and promotes proliferation (28).
a3b1 integrin may also transduce signals antagonistic against
those from a5b1 and other integrins, as the ablation of a3b1
integrin from epithelial cells results in an enhanced formation
of stress fibers and focal contacts (29, 30), suggesting that a3b1
integrin transduces a signal that trans-dominantly inhibits the
cytoskeletal reorganization induced by other integrins. The
molecular mechanism underlying these phenomena, however,
has not been addressed in depth. Our results clearly show that
the signaling pathway activated by a3b1 integrin is distinct
from that activated by a5b1 integrin with respect to the phos-
phorylation of FAK and p130Cas, the coupling of CrkII with
p130Cas and DOCK180, and the activation of Rac and Rho,
resulting in enhanced cell migration on LN-10/11 with a con-
comitant suppression of stress fiber and focal contact forma-
tion. This is the first report demonstrating a clear distinction in
signaling events elicited by a3b1 and a5b1 integrins.
Activation of Rho Family GTPases Is Substrate-dependent—
Most studies of ECM-dependent activation of Rho family
GTPases have been performed on fibroblasts (e.g. Swiss or NIH
3T3 fibroblasts) adhering to FN. FN activates Rho (31, 32) as
well as Rac and Cdc42 (33, 34), although most studies do not
examine both Rho and Rac/Cdc42 activation in the same cell
system. Our data demonstrate that, in A549 cells, LN-10/11
preferentially activate Rac, whereas FN activates Rho. As the
adhesion of A549 cells to LN-10/11 and FN is mediated by a3b1
and a5b1 integrins, respectively, our results indicate that dif-
ferent integrins transduce signals differentially activating the
Rho family of GTPases. Recently, Wenk et al. (32) reported that
tenascin-C suppresses the activation of Rho and subsequent
stress fiber formation in cells plated on three-dimensional fi-
brin-FN matrix, again suggesting the substrate-dependent ac-
tivation of Rho family GTPases.
Signaling pathways activating Rho family GTPases and
their downstream effectors may vary considerably among dif-
ferent cell types. Constitutively active Rac is sufficient to in-
duce membrane ruffles in Swiss 3T3 and NIH 3T3 fibroblasts
(3), although both the Rac-mediated pathway and the phospho-
rylation of adducin by the Rho/Rho kinase pathway is required
for 12-O-tetradecanoylphorbol-13-acetate-induced membrane
ruffling in Madin-Darby canine kidney epithelial cells (35). In
epithelial cells, p120Ctn, a putative negative regulator of cad-
herin-mediated cell-cell adhesion, inhibits Rho activation when
present as a cadherin-unbound form (36, 37), supporting the
possibility that signaling pathways regulating the activation of
Rho family GTPases differ in epithelial cells from those in
fibroblasts.
LN-10/11 Stimulate Cell Migration via p130Cas-CrkII-
DOCK180-Rac Pathway—The dominant-negative form of Rac
(RacAsn-17) blocks integrin-mediated cell migration (5, 7), link-
ing Rac activation to cell migration. To explore the mechanism
underlying cell migration over LN-10/11, we examined the
tyrosine phosphorylation state of FAK and p130Cas, molecules
implicated in signaling events promoting cell migration (38).
p130Cas is preferentially tyrosine-phosphorylated on LN-10/11,
whereas FAK is more phosphorylated on FN than on LN-10/11,
suggesting the involvement of p130Cas tyrosine phosphoryla-
tion in LN-10/11-driven cell migration. Tyrosine phosphoryla-
tion of p130Cas has also been implicated as a critical event in
the migration and invasion of tumor cells. Pancreatic carci-
noma cells selected for high migration in vitro exhibited in-
creased tyrosine phosphorylation of p130Cas (5). Transfection of
wild-type p130Cas is sufficient to promote tumor cell migration;
a non-phosphorylatable p130Cas mutant lacking the substrate
domain cannot mediate this effect (5). Similar results were also
obtained with COS cells transfected with either wild-type or
the substrate domain-deficient mutant of p130Cas (7). Tyrosine
phosphorylation of the substrate domain of p130Cas is depend-
ent on both FAK and Src family kinases, the latter serving as
the major kinases phosphorylating the substrate domain,
whereas the former serving as a template for the assemblage of
a ternary complex consisting of FAK, p130Cas, and Src kinases
(8, 39). Disruption of this ternary complex by overexpression of
FAK mutants defective in either Src kinase binding or p130Cas
binding, as well as by overexpression of the p130Cas SH3 do-
main competing with endogenous p130Cas for FAK binding, has
been shown to suppress integrin-mediated cell migration (40,
41). In addition, cells derived from either p130Cas-deficient or
Src/Yes/Fyn triple-deficient mouse embryos are significantly
less motile than wild-type cells (8, 42), supporting the impor-
tance of the tyrosine phosphorylation of p130Cas in cell
migration.
The coupling of p130Cas to CrkII may serve as a molecular
switch for induction of cell migration through Rac activation (5,
7, 41). Consistent with this view, our data demonstrate that
coupling of CrkII with p130Cas is increased in cells plated on
LN-10/11, not FN. Increased formation of the p130Cas-CrkII
complex is accompanied by an increased association of
DOCK180 with this complex, enhancing Rac activation.
DOCK180 serves as the major guanine nucleotide exchange
factor for Rac in integrin-dependent cell migration (6, 7). Rac
activation also down-regulates Rho activity (43–45); the mini-
mal Rho activation in cells adhering to LN-10/11 may result
from enhanced Rac activation on LN-10/11.
Possible Mechanisms Directing the Signaling Pathways
through Different Integrins—Our data suggest that LN-10/11
and FN differentially activate Rho family GTPases through
distinct signaling pathways involving the a3b1 and a5b1 inte-
grins. The mechanism directing the activation of individual
signaling pathways specific to each integrin type remains un-
clear. Membrane proteins associating with a subset of inte-
grins, such as transmembrane-4 superfamily proteins and
caveolin-1 (46, 47), may control the activation of integrin type-
specific signaling pathways. Many transmembrane-4 super-
family proteins associate with a3b1, a6b1, and some other b1-
containing integrins. CD151, selectively associated with a3b1
in stringent detergents (48), is involved in integrin-mediated
cell migration and invasion, as antibodies against CD151 in-
hibit the migration of neutrophils and endothelial cells (48, 49).
In addition, a monoclonal antibody inhibiting the in vivo me-
tastasis of human epidermoid carcinoma cells was found to be
directed to CD151 (50). Given that the association of CD151
with a3b1 integrin is highly stable and stoichiometric and that
phosphatidylinositol 4-kinase is associated with the CD151-
a3b1 integrin complex (48), CD151 may specify the signaling
pathways downstream of a3b1 integrin. In contrast, caveolin-1,
a membrane protein localizing to caveolae, associates with a5b1
and other integrins, but not with a3b1, resulting in the recruit-
ment of Shc via activation of Fyn (47, 51). Although it is not
clear if the association of transmembrane-4 superfamily pro-
teins and/or caveolin-1 with integrin subsets directs the differ-
ential signaling events occurring on LN-10/11 and FN, further
studies will shed a light on the molecular mechanisms operat-
ing in ECM-regulated, cellular behaviors in physiological and
pathological conditions.
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